Recognitive biomimetic networks with moiety imprinting for intelligent drug delivery

Mark E. Byrne, J. Zachary Hilt, Nicholas A. Peppas

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Molecular imprinting techniques have been developed for the preparation of biomimetic polymer networks that can recognize a general moiety, D-glucose, and the novel evaluation of loading and release of a larger molecule with glucose as an integral part of its structure [i.e., fluorescently tagged glucose (2-(N-(7-nitrobenz-2-oxa1,3-diazol-4-yl)amino)-2-deoxy-glucose) or 2-NBDG]. Poly (acrylamide-co-poly(ethylene glycol)dimethacrylate) networks with varying crosslinking monomer percentages (80, 67, and 30%) and crosslinker lengths (average number of ethylene glycol units of 1, 4, and 14) were prepared and characterized using a novel fluorescent microscopy technique, which allowed for microscale observation of the dynamic binding and release of 2-NBDG within the polymer film. Experimental results indicate that tighter mesh-sized networks had increased affinity and capacity towards the glucose functionalized molecule as well as increased diffusional transport times, indicating the strong potential to load significantly higher amounts of therapeutic within intelligent carriers as well as control and extend the rate of release via macromolecular structure.

Original languageEnglish
Pages (from-to)137-147
Number of pages11
JournalJournal of Biomedical Materials Research - Part A
Volume84
Issue number1
DOIs
StatePublished - Jan 1 2008

Funding

FundersFunder number
National Institute of Biomedical Imaging and BioengineeringR01EB000246

    Keywords

    • Biomimetic
    • Controlled release
    • Drug delivery
    • Molecular imprinting
    • Sustained release

    ASJC Scopus subject areas

    • Ceramics and Composites
    • Biomaterials
    • Biomedical Engineering
    • Metals and Alloys

    Fingerprint

    Dive into the research topics of 'Recognitive biomimetic networks with moiety imprinting for intelligent drug delivery'. Together they form a unique fingerprint.

    Cite this